Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Zuyi Yang, orcid.org/0009-0000-3317-4136
Metabolism 93 (1), 103109
SeekPeptides provides evidence-based guides, dosage calculators , and comprehensive protocol resources specifically to help researchers make informed decisions based on science rather than social media advertising
Conclusion Understanding changes in clinical characteristics and treatment patterns over time among new users of SGLT2i or GLP-1 RA in the US as described in this observational study is important to inform and contextualize future studies assessing cardiorenal outcomes for these and additional treatments, including finerenone, for individuals with CKD and type 2 diabetes
